-
Mashup Score: 1
WASHINGTON — Patients with COPD on budesonide/glycopyrrolate/formoterol fumarate within 30 days of an exacerbation had fewer future exacerbations, according to data presented at the American Thoracic Society International Conference.“Exacerbations and Real-world Outcomes [EROS] informs us that triple therapy begun immediately after both moderate and severe exacerbations improved
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Chronic Obstructive Pulmonary Disease and Pneumonia in New Users of Combination Maintenance Inhalers - 11 month(s) ago
This cohort study uses commercial insurance claims to compare the incidence of first moderate or severe chronic obstructive pulmonary disease (COPD) exacerbation and first pneumonia hospitalization among patients with COPD who started using inhalers with long-acting muscarinic antagonists and…
Source: jamanetwork.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
UC Davis Health will integrate Propeller Health’s remote monitoring platform into its own electronic health record (EHR) system.
Categories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0A Call for the United States to Accelerate the Implementation of Reliever Combination ICS-Formoterol Inhalers in Asthma - PubMed - 1 year(s) ago
A Call for the United States to Accelerate the Implementation of Reliever Combination ICS-Formoterol Inhalers in Asthma
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Background While inhaled corticosteroids (ICS) are considered the essential foundation of most asthma therapy, ICS inhaler nonadherence is a notoriously common problem and a significant cause of asthma-related morbidity. Partially acknowledging the problem of nonadherence, international organizations recently made paradigm-shifting recommendations that all patients with mild-to-moderate…
Source: BioMed CentralCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Fewer patients made critical and overall errors using the ELLIPTA inhaler versus BREEZHALER after reading the PIL.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Liability Fears Keep Some Schools From Stocking Asthma Inhalers - 1 year(s) ago
FRIDAY, Nov. 11, 2022 (HealthDay News) — It’s a potentially deadly issue: Some U.S. school administrators don’t keep life-saving albuterol asthma inhalers on hand because they’re afraid of getting sued for misuse. That’s true even in states like Illinois, where strong “stock albuterol” laws are on …
Source: Consumer Health News | HealthDayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5Patient/carer input needed for an updated Cochrane Airways review on combined inhalers for stable COPD - 2 year(s) ago
– Airways Lungs & Airways Skills / interests: Consumer (public, patient, carer) input Background Chronic obstructive pulmonary disease (COPD) is a long-term lung…
Source: taskexchange.cochrane.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Digital Inhalers and Remote Patient Monitoring for Asthma - 2 year(s) ago
Digital inhaler systems, remote patient monitoring, and remote therapeutic monitoring offer great promise as diagnostic tools and therapeutic interventions to improve adherence and inhaler technique for patients with difficult-to-control asthma. In turn, improvements in adherence and inhaler technique may translate into decreasing the need for high side effect treatments such as oral…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 1Pharmalittle: Moderna chair defends executive hiring process; analysis finds monopoly tactics preserve inhaler revenues - 2 year(s) ago
Moderna chair Noubar Afeyan launched an unflinching defense of the board’s executive hiring process after it was forced to fire its new chief financial officer last week.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
“... triple therapy begun immediately after both moderate and severe #exacerbations improved outcomes compared to all combinations of #inhalers that were used in the month before the index exacerbation,” Charlie Strange, MD, at @MedUnivSC, told Healio. https://t.co/lh9wbqE9zy